Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1985 2
1988 1
1990 2
1991 5
1992 5
1993 9
1994 8
1995 12
1996 8
1997 4
1998 6
1999 9
2000 7
2001 2
2002 1
2003 5
2004 3
2005 7
2006 5
2007 1
2008 2
2009 6
2010 6
2011 5
2012 11
2013 11
2014 10
2015 9
2016 16
2017 11
2018 5
2019 4
2020 4
2021 4
2022 5
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR; International Vidaza High-Risk MDS Survival Study Group. Fenaux P, et al. Lancet Oncol. 2009 Mar;10(3):223-32. doi: 10.1016/S1470-2045(09)70003-8. Epub 2009 Feb 21. Lancet Oncol. 2009. PMID: 19230772 Free PMC article. Clinical Trial.
Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network.
Itzykson R, Santini V, Thepot S, Ades L, Chaffaut C, Giagounidis A, Morabito M, Droin N, Lübbert M, Sapena R, Nimubona S, Goasguen J, Wattel E, Zini G, Torregrosa Diaz JM, Germing U, Pelizzari AM, Park S, Jaekel N, Metzgeroth G, Onida F, Navarro R, Patriarca A, Stamatoullas A, Götze K, Puttrich M, Mossuto S, Solary E, Gloaguen S, Chevret S, Chermat F, Platzbecker U, Fenaux P. Itzykson R, et al. Among authors: wattel e. J Clin Oncol. 2023 Apr 1;41(10):1888-1897. doi: 10.1200/JCO.22.00437. Epub 2022 Dec 1. J Clin Oncol. 2023. PMID: 36455187 Clinical Trial.
How mRNA is misspliced in acute myelogenous leukemia (AML)?
Mohamed AM, Thénoz M, Solly F, Balsat M, Mortreux F, Wattel E. Mohamed AM, et al. Among authors: wattel e. Oncotarget. 2014 Oct 30;5(20):9534-45. doi: 10.18632/oncotarget.2304. Oncotarget. 2014. PMID: 25375204 Free PMC article. Review.
Potential Role of OCT4 in Leukemogenesis.
Picot T, Kesr S, Wu Y, Aanei CM, Flandrin-Gresta P, Tondeur S, Tavernier E, Wattel E, Guyotat D, Campos L. Picot T, et al. Among authors: wattel e. Stem Cells Dev. 2017 Nov 15;26(22):1637-1647. doi: 10.1089/scd.2017.0134. Epub 2017 Oct 16. Stem Cells Dev. 2017. PMID: 28911263
Chronic myelomonocytic leukemia: from biology to therapy.
Cambier N, Baruchel A, Schlageter MH, Menot ML, Wattel E, Fenaux P, Chomienne C. Cambier N, et al. Among authors: wattel e. Hematol Cell Ther. 1997 Apr;39(2):41-8. doi: 10.1007/s00282-997-0041-4. Hematol Cell Ther. 1997. PMID: 9168299 Review.
190 results